Literature DB >> 7662623

Macular microcirculation in cystoid maculopathy of diabetic patients.

O Arend1, A Remky, A Harris, B Bertram, M Reim, S Wolf.   

Abstract

BACKGROUND: In patients with diabetic macular oedema and central cysts ischaemia of the retina appears to be an important contributing factor in the pathogenesis of cysts. This study was performed to further elucidate the role of the inner retinal microcirculation in diabetic cystoid macular oedema (CMO).
METHODS: Video fluorescein angiography allows visualisation of the macular microvasculature and measurements of the capillary blood velocity (CBV), foveal avascular zone (FAZ), and perifoveal intercapillary area (PIA, characterising capillary density).
RESULTS: Twenty three diabetic subjects with CMO, matched diabetic patients without macular oedema (n = 23), and healthy subjects (n = 23) were included. CBV, PIA, and FAZ did not differ significantly among diabetic groups regardless of presence of cystoid changes. CBV was significantly reduced (p < 0.0001) and PIA was more than doubled in both diabetic groups (p < 0.0001) when compared with healthy subjects. Furthermore, FAZ showed a nearly doubled size in diabetic patients without macular oedema (p < 0.01) and a less pronounced enlargement (by 29%) in diabetics with CMO (p < 0.05).
CONCLUSION: The results indicate that the retinal microcirculation in diabetic patients is markedly altered when compared with healthy subjects, regardless of CMO presence. In CMO patients the microcirculatory changes are similar to those of diabetic patients without macular oedema. Thus inner retinal perfusion does not contribute to tissue ischaemia leading to cystoid formations in diabetic maculopathy.

Entities:  

Mesh:

Year:  1995        PMID: 7662623      PMCID: PMC505186          DOI: 10.1136/bjo.79.7.628

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  STUDIES OF THE RETINAL CAPILLARIES IN RELATION TO DIABETIC AND OTHER RETINOPATHIES.

Authors:  N ASHTON
Journal:  Br J Ophthalmol       Date:  1963-09       Impact factor: 4.638

2.  Cystoid maculopathy in diabetics.

Authors:  A Patz
Journal:  Arch Ophthalmol       Date:  1976-05

Review 3.  Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973.

Authors:  N Ashton
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

4.  Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study.

Authors:  J D Gass; E W Norton
Journal:  Arch Ophthalmol       Date:  1966-11

5.  Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances.

Authors:  A M Hamilton; E M Kohner; D Rosen; A C Bird; C T Dollery
Journal:  Br J Ophthalmol       Date:  1979-06       Impact factor: 4.638

6.  Pathology of human cystoid macular edema.

Authors:  M Yanoff; B S Fine; A J Brucker; R C Eagle
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

7.  Natural course of nonaphakic cystoid macular edema.

Authors:  G Coscas; A Gaudric
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

8.  Animal modeling of cystoid macular edema.

Authors:  M O Tso
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

9.  Pathology of cystoid macular edema.

Authors:  M O Tso
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

10.  Macular edema and cystoid macular edema.

Authors:  B S Fine; A J Brucker
Journal:  Am J Ophthalmol       Date:  1981-10       Impact factor: 5.258

View more
  9 in total

1.  Macular microcirculation in patients with epiretinal membrane before and after surgery.

Authors:  Tomoko Yagi; Kumi Sakata; Hideharu Funatsu; Hidetaka Noma; Kaori Yamamoto; Sadao Hori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-16       Impact factor: 3.117

2.  Exaggerated relative nasal-temporal asymmetry of macular capillary blood flow in patients with clinically significant diabetic macular oedema.

Authors:  C Hudson; J G Flanagan; G S Turner; H C Chen; M H Rawji; D McLeod
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

3.  Assessment of potential vessel segmentation pitfalls in the analysis of blood flow velocity using the Retinal Function Imager.

Authors:  Gábor Márk Somfai; Jing Tian; Delia Cabrera DeBuc
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-15       Impact factor: 3.117

4.  Noninvasive imaging of the foveal avascular zone with high-speed, phase-variance optical coherence tomography.

Authors:  Dae Yu Kim; Jeff Fingler; Robert J Zawadzki; Susanna S Park; Lawrence S Morse; Daniel M Schwartz; Scott E Fraser; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

5.  Subtle changes in diabetic retinas localised in 3D using OCT.

Authors:  Edmund Arthur; Joel A Papay; Bryan P Haggerty; Christopher A Clark; Ann E Elsner
Journal:  Ophthalmic Physiol Opt       Date:  2018-07-26       Impact factor: 3.117

Review 6.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

7.  High-resolution wide-field imaging of perfused capillaries without the use of contrast agent.

Authors:  Darin A Nelson; Zvia Burgansky-Eliash; Hila Barash; Anat Loewenstein; Adiel Barak; Elisha Bartov; Tali Rock; Amiram Grinvald
Journal:  Clin Ophthalmol       Date:  2011-08-09

8.  Non-Proliferative Diabetic Retinopathy Is Characterized by Nonuniform Alterations of Peripapillary Capillary Networks.

Authors:  Dong An; Erandi Chandrasekera; Dao-Yi Yu; Chandrakumar Balaratnasingam
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

Review 9.  Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema.

Authors:  Hidetaka Noma; Kanako Yasuda; Masahiko Shimura
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.